Print FriendlyTechnology for Infection and Viral Applications
S00014: Bushman
Method of Rapidly Identifying Inhibitors of Topoisomerase DNA Religation
High throughput screen for compounds that modulate topoisomerase activity
S97022B: Bushman
Assay for Integration Inhibitors Using Pre-Integration Complexes
A screen for viral integrase inhibitors
S00010B: Noel
Modulation of Mevalonate-Independent Isoprenoid Biosynthetic Pathway
Templates for the design of novel antibacterial and antiparasitic drugs
S05006: Sefton
Methods of Inhibiting Poxvirus Growth
Targets for the development of anti-smallpox drugs
S07014: Young
Non-Nucleoside Reverse Transcriptase Inhibitors
Novel NNRTIs, compounds and pharmaceutical compositions for reducing HIV infection and replication.
S07001: Young
A Novel Antitoxin and Vaccine Platform Based on Nodavirus VLPS
A novel, chimeric virus-like particle (VLP) capable of multivalent display of PA shows significant advantages over existing monovalent PA immunogens for anthrax toxin. Studies indicate VLP-PA complex may eliminate the need for lengthy immunization schedules by providing immunity after a single injection, and has potential to generate effective vaccines against other pathogens, including combination vaccines immunizing against multiple toxins.